Clinical Gastroenterology Vol.35 No.05 ( May, 2020)

Thesis List

• 0 Editorial
  Narikazu Boku

• 1 General Remarks of Cancer Immunity
  Hisashi Wada

• 2 The History of Cancer Immunotherapy
  Hiromichi Nakajima

• 3 Overview of Immune Checkpoint Inhibitors
  Kazuki Nozawa

• 4-1 Current Status of Immune Checkpoint Inhibitors for Gastrointestinal Cancer
  Takayuki Yamazaki

• 4-2 Immune Checkpoint Inhibitors in Hepatobiliary and Pancreatic Cancer
  Tomoyuki Satake

• 5 Current Landscape of Biomarkers for Immune Checkpoint Inhibitor
  Yasuhiro Sato

• 6 Immune Checkpoint Inhibitors in Combination with Other Agents: Current Knowledge and Future Research Directions
  Seiichiro Mitani

• 7-1 General Remarks on Immune Related Adverse Events (irAE) and Their Management
  Makoto Arai

• 7-2 Endocrine Dysfunction Induced by Immune Checkpoint Inhibitors
  Tomoko Kobayashi

• 7-3 Neuromuscular Adverse Events Associated with Immune Checkpoint Inhibitors
  Morinobu Seki

• 8-1 Regulatory T Cells in Cancer Immunotherapy
  Hirotaka Wada

• 8-2 Cancer Immunotherapy Using Genetically Engineered Immune Cells
  Kosuke Jozaki

• 8-3 Clinical Development of Cancer Immunotherapy and Future Prospect
  Shigehisa Kitano

Series List

• 10 Liftal® K
  Hiroyuki Ono

  Information of New Drugs

• 11 Endoscopic Diagnosis of Invasive Colorectal Laterally Spreading Tumor
  Kazunori Takada

  Endoscopy